TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/12/26 17:33 | 5/6/26 | BUDZ | Weed, Inc. | NV | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | S.m | -3 | 0.0312 | 0 | -111 | 0 | 30,100 | I | ||||||||||||||
6/11/26 16:10 | 6/9/26 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | 1 | 1 | S.d | -60 | 11.29 | 0 | -5 | 98 | D | |||||||||||||||
6/10/26 17:22 | 6/9/26 | ULS | Ul Solutions Inc. | DE | Health | Biolab | Testing Laboratories | 5 | 9 | S.dm | -7,773 | 96.50 | 0 | -81 | 403 | D | |||||||||||||||
6/8/26 16:04 | 6/4/26 | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | 3 | 5 | S.d | -5,448 | 95.54 | 0 | -57 | 308 | D | |||||||||||||||
6/1/26 16:27 | 3/17/26 | MEDP | Medpace Holdings, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 2 | 2 | S.d | -21,793 | 453.50 | 0 | -48 | 35 | D | |||||||||||||||
4/7/26 20:26 | 4/7/26 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 3 | 3 | S.d | -50 | 1.49 | 0 | -33 | 5,081 | D | |||||||||||||||
3/19/26 16:05 | 3/17/26 | MXCT | Maxcyte, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | S | -8 | 0.8150 | 0 | -10 | 152 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |